COVID-19 Impact on Global Tofacitinib Market Insights, Forecast to 2026
Tofacitinib market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tofacitinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Tofacitinib market is segmented into
The Tofacitinib market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tofacitinib market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tofacitinib Market Share Analysis
Tofacitinib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tofacitinib business, the date to enter into the Tofacitinib market, Tofacitinib product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Tofacitinib market is segmented into
- 5mg*60 Tablets
- 5mg*10 Tablets
- 10mg*10 Tablets
- 5mg*30 Tablets
- 5mg*14 Tablets
- 10mg*14 Tablets
- Rheumatoid Arthritis
- Ulcerative Colitis
- Psoriasis
- Other
The Tofacitinib market is analysed and market size information is provided by regions (countries).
The key regions covered in the Tofacitinib market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tofacitinib Market Share Analysis
Tofacitinib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tofacitinib business, the date to enter into the Tofacitinib market, Tofacitinib product introduction, recent developments, etc.
The major vendors covered:
- Pfizer
- Globe Pharmaceuticals
- Delta Pharma Limited
- Beacon Pharmaceuticals
- Drug International
1 STUDY COVERAGE
1.1 Tofacitinib Product Introduction
1.2 Market Segments
1.3 Key Tofacitinib Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tofacitinib Market Size Growth Rate by Type
1.4.2 5mg*60 Tablets
1.4.3 5mg*10 Tablets
1.4.4 10mg*10 Tablets
1.4.5 5mg*30 Tablets
1.4.6 5mg*14 Tablets
1.4.7 10mg*14 Tablets
1.5 Market by Application
1.5.1 Global Tofacitinib Market Size Growth Rate by Application
1.5.2 Rheumatoid Arthritis
1.5.3 Ulcerative Colitis
1.5.4 Psoriasis
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Tofacitinib Industry Impact
1.6.1 How the Covid-19 is Affecting the Tofacitinib Industry
1.6.1.1 Tofacitinib Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Tofacitinib Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Tofacitinib Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Tofacitinib Market Size Estimates and Forecasts
2.1.1 Global Tofacitinib Revenue 2015-2026
2.1.2 Global Tofacitinib Sales 2015-2026
2.2 Tofacitinib Market Size by Region: 2020 Versus 2026
2.2.1 Global Tofacitinib Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tofacitinib Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL TOFACITINIB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Tofacitinib Sales by Manufacturers
3.1.1 Tofacitinib Sales by Manufacturers (2015-2020)
3.1.2 Tofacitinib Sales Market Share by Manufacturers (2015-2020)
3.2 Tofacitinib Revenue by Manufacturers
3.2.1 Tofacitinib Revenue by Manufacturers (2015-2020)
3.2.2 Tofacitinib Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tofacitinib Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tofacitinib Revenue in 2019
3.2.5 Global Tofacitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tofacitinib Price by Manufacturers
3.4 Tofacitinib Manufacturing Base Distribution, Product Types
3.4.1 Tofacitinib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tofacitinib Product Type
3.4.3 Date of International Manufacturers Enter into Tofacitinib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Tofacitinib Market Size by Type (2015-2020)
4.1.1 Global Tofacitinib Sales by Type (2015-2020)
4.1.2 Global Tofacitinib Revenue by Type (2015-2020)
4.1.3 Tofacitinib Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tofacitinib Market Size Forecast by Type (2021-2026)
4.2.1 Global Tofacitinib Sales Forecast by Type (2021-2026)
4.2.2 Global Tofacitinib Revenue Forecast by Type (2021-2026)
4.2.3 Tofacitinib Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tofacitinib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Tofacitinib Market Size by Application (2015-2020)
5.1.1 Global Tofacitinib Sales by Application (2015-2020)
5.1.2 Global Tofacitinib Revenue by Application (2015-2020)
5.1.3 Tofacitinib Price by Application (2015-2020)
5.2 Tofacitinib Market Size Forecast by Application (2021-2026)
5.2.1 Global Tofacitinib Sales Forecast by Application (2021-2026)
5.2.2 Global Tofacitinib Revenue Forecast by Application (2021-2026)
5.2.3 Global Tofacitinib Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Tofacitinib by Country
6.1.1 North America Tofacitinib Sales by Country
6.1.2 North America Tofacitinib Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tofacitinib Market Facts & Figures by Type
6.3 North America Tofacitinib Market Facts & Figures by Application
7 EUROPE
7.1 Europe Tofacitinib by Country
7.1.1 Europe Tofacitinib Sales by Country
7.1.2 Europe Tofacitinib Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tofacitinib Market Facts & Figures by Type
7.3 Europe Tofacitinib Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Tofacitinib by Region
8.1.1 Asia Pacific Tofacitinib Sales by Region
8.1.2 Asia Pacific Tofacitinib Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tofacitinib Market Facts & Figures by Type
8.3 Asia Pacific Tofacitinib Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Tofacitinib by Country
9.1.1 Latin America Tofacitinib Sales by Country
9.1.2 Latin America Tofacitinib Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tofacitinib Market Facts & Figures by Type
9.3 Central & South America Tofacitinib Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Tofacitinib by Country
10.1.1 Middle East and Africa Tofacitinib Sales by Country
10.1.2 Middle East and Africa Tofacitinib Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tofacitinib Market Facts & Figures by Type
10.3 Middle East and Africa Tofacitinib Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Tofacitinib Products Offered
11.1.5 Pfizer Recent Development
11.2 Globe Pharmaceuticals
11.2.1 Globe Pharmaceuticals Corporation Information
11.2.2 Globe Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 Globe Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Globe Pharmaceuticals Tofacitinib Products Offered
11.2.5 Globe Pharmaceuticals Recent Development
11.3 Delta Pharma Limited
11.3.1 Delta Pharma Limited Corporation Information
11.3.2 Delta Pharma Limited Description, Business Overview and Total Revenue
11.3.3 Delta Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Delta Pharma Limited Tofacitinib Products Offered
11.3.5 Delta Pharma Limited Recent Development
11.4 Beacon Pharmaceuticals
11.4.1 Beacon Pharmaceuticals Corporation Information
11.4.2 Beacon Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Beacon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Beacon Pharmaceuticals Tofacitinib Products Offered
11.4.5 Beacon Pharmaceuticals Recent Development
11.5 Drug International
11.5.1 Drug International Corporation Information
11.5.2 Drug International Description, Business Overview and Total Revenue
11.5.3 Drug International Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Drug International Tofacitinib Products Offered
11.5.5 Drug International Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Tofacitinib Products Offered
11.1.5 Pfizer Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Tofacitinib Market Estimates and Projections by Region
12.1.1 Global Tofacitinib Sales Forecast by Regions 2021-2026
12.1.2 Global Tofacitinib Revenue Forecast by Regions 2021-2026
12.2 North America Tofacitinib Market Size Forecast (2021-2026)
12.2.1 North America: Tofacitinib Sales Forecast (2021-2026)
12.2.2 North America: Tofacitinib Revenue Forecast (2021-2026)
12.2.3 North America: Tofacitinib Market Size Forecast by Country (2021-2026)
12.3 Europe Tofacitinib Market Size Forecast (2021-2026)
12.3.1 Europe: Tofacitinib Sales Forecast (2021-2026)
12.3.2 Europe: Tofacitinib Revenue Forecast (2021-2026)
12.3.3 Europe: Tofacitinib Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tofacitinib Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tofacitinib Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tofacitinib Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tofacitinib Market Size Forecast by Region (2021-2026)
12.5 Latin America Tofacitinib Market Size Forecast (2021-2026)
12.5.1 Latin America: Tofacitinib Sales Forecast (2021-2026)
12.5.2 Latin America: Tofacitinib Revenue Forecast (2021-2026)
12.5.3 Latin America: Tofacitinib Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tofacitinib Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tofacitinib Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tofacitinib Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tofacitinib Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tofacitinib Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Tofacitinib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Tofacitinib Product Introduction
1.2 Market Segments
1.3 Key Tofacitinib Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Tofacitinib Market Size Growth Rate by Type
1.4.2 5mg*60 Tablets
1.4.3 5mg*10 Tablets
1.4.4 10mg*10 Tablets
1.4.5 5mg*30 Tablets
1.4.6 5mg*14 Tablets
1.4.7 10mg*14 Tablets
1.5 Market by Application
1.5.1 Global Tofacitinib Market Size Growth Rate by Application
1.5.2 Rheumatoid Arthritis
1.5.3 Ulcerative Colitis
1.5.4 Psoriasis
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Tofacitinib Industry Impact
1.6.1 How the Covid-19 is Affecting the Tofacitinib Industry
1.6.1.1 Tofacitinib Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Tofacitinib Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Tofacitinib Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Tofacitinib Market Size Estimates and Forecasts
2.1.1 Global Tofacitinib Revenue 2015-2026
2.1.2 Global Tofacitinib Sales 2015-2026
2.2 Tofacitinib Market Size by Region: 2020 Versus 2026
2.2.1 Global Tofacitinib Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Tofacitinib Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL TOFACITINIB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Tofacitinib Sales by Manufacturers
3.1.1 Tofacitinib Sales by Manufacturers (2015-2020)
3.1.2 Tofacitinib Sales Market Share by Manufacturers (2015-2020)
3.2 Tofacitinib Revenue by Manufacturers
3.2.1 Tofacitinib Revenue by Manufacturers (2015-2020)
3.2.2 Tofacitinib Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Tofacitinib Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Tofacitinib Revenue in 2019
3.2.5 Global Tofacitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Tofacitinib Price by Manufacturers
3.4 Tofacitinib Manufacturing Base Distribution, Product Types
3.4.1 Tofacitinib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tofacitinib Product Type
3.4.3 Date of International Manufacturers Enter into Tofacitinib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Tofacitinib Market Size by Type (2015-2020)
4.1.1 Global Tofacitinib Sales by Type (2015-2020)
4.1.2 Global Tofacitinib Revenue by Type (2015-2020)
4.1.3 Tofacitinib Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Tofacitinib Market Size Forecast by Type (2021-2026)
4.2.1 Global Tofacitinib Sales Forecast by Type (2021-2026)
4.2.2 Global Tofacitinib Revenue Forecast by Type (2021-2026)
4.2.3 Tofacitinib Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Tofacitinib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Tofacitinib Market Size by Application (2015-2020)
5.1.1 Global Tofacitinib Sales by Application (2015-2020)
5.1.2 Global Tofacitinib Revenue by Application (2015-2020)
5.1.3 Tofacitinib Price by Application (2015-2020)
5.2 Tofacitinib Market Size Forecast by Application (2021-2026)
5.2.1 Global Tofacitinib Sales Forecast by Application (2021-2026)
5.2.2 Global Tofacitinib Revenue Forecast by Application (2021-2026)
5.2.3 Global Tofacitinib Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Tofacitinib by Country
6.1.1 North America Tofacitinib Sales by Country
6.1.2 North America Tofacitinib Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Tofacitinib Market Facts & Figures by Type
6.3 North America Tofacitinib Market Facts & Figures by Application
7 EUROPE
7.1 Europe Tofacitinib by Country
7.1.1 Europe Tofacitinib Sales by Country
7.1.2 Europe Tofacitinib Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tofacitinib Market Facts & Figures by Type
7.3 Europe Tofacitinib Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Tofacitinib by Region
8.1.1 Asia Pacific Tofacitinib Sales by Region
8.1.2 Asia Pacific Tofacitinib Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Tofacitinib Market Facts & Figures by Type
8.3 Asia Pacific Tofacitinib Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Tofacitinib by Country
9.1.1 Latin America Tofacitinib Sales by Country
9.1.2 Latin America Tofacitinib Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Tofacitinib Market Facts & Figures by Type
9.3 Central & South America Tofacitinib Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Tofacitinib by Country
10.1.1 Middle East and Africa Tofacitinib Sales by Country
10.1.2 Middle East and Africa Tofacitinib Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Tofacitinib Market Facts & Figures by Type
10.3 Middle East and Africa Tofacitinib Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Tofacitinib Products Offered
11.1.5 Pfizer Recent Development
11.2 Globe Pharmaceuticals
11.2.1 Globe Pharmaceuticals Corporation Information
11.2.2 Globe Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 Globe Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Globe Pharmaceuticals Tofacitinib Products Offered
11.2.5 Globe Pharmaceuticals Recent Development
11.3 Delta Pharma Limited
11.3.1 Delta Pharma Limited Corporation Information
11.3.2 Delta Pharma Limited Description, Business Overview and Total Revenue
11.3.3 Delta Pharma Limited Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Delta Pharma Limited Tofacitinib Products Offered
11.3.5 Delta Pharma Limited Recent Development
11.4 Beacon Pharmaceuticals
11.4.1 Beacon Pharmaceuticals Corporation Information
11.4.2 Beacon Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Beacon Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Beacon Pharmaceuticals Tofacitinib Products Offered
11.4.5 Beacon Pharmaceuticals Recent Development
11.5 Drug International
11.5.1 Drug International Corporation Information
11.5.2 Drug International Description, Business Overview and Total Revenue
11.5.3 Drug International Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Drug International Tofacitinib Products Offered
11.5.5 Drug International Recent Development
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description, Business Overview and Total Revenue
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Tofacitinib Products Offered
11.1.5 Pfizer Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Tofacitinib Market Estimates and Projections by Region
12.1.1 Global Tofacitinib Sales Forecast by Regions 2021-2026
12.1.2 Global Tofacitinib Revenue Forecast by Regions 2021-2026
12.2 North America Tofacitinib Market Size Forecast (2021-2026)
12.2.1 North America: Tofacitinib Sales Forecast (2021-2026)
12.2.2 North America: Tofacitinib Revenue Forecast (2021-2026)
12.2.3 North America: Tofacitinib Market Size Forecast by Country (2021-2026)
12.3 Europe Tofacitinib Market Size Forecast (2021-2026)
12.3.1 Europe: Tofacitinib Sales Forecast (2021-2026)
12.3.2 Europe: Tofacitinib Revenue Forecast (2021-2026)
12.3.3 Europe: Tofacitinib Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Tofacitinib Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Tofacitinib Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Tofacitinib Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Tofacitinib Market Size Forecast by Region (2021-2026)
12.5 Latin America Tofacitinib Market Size Forecast (2021-2026)
12.5.1 Latin America: Tofacitinib Sales Forecast (2021-2026)
12.5.2 Latin America: Tofacitinib Revenue Forecast (2021-2026)
12.5.3 Latin America: Tofacitinib Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Tofacitinib Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Tofacitinib Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Tofacitinib Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Tofacitinib Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Tofacitinib Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Tofacitinib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Tofacitinib Market Segments
Table 2. Ranking of Global Top Tofacitinib Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tofacitinib Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 5mg*60 Tablets
Table 5. Major Manufacturers of 5mg*10 Tablets
Table 6. Major Manufacturers of 10mg*10 Tablets
Table 7. Major Manufacturers of 5mg*30 Tablets
Table 8. Major Manufacturers of 5mg*14 Tablets
Table 9. Major Manufacturers of 10mg*14 Tablets
Table 10. COVID-19 Impact Global Market: (Four Tofacitinib Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Tofacitinib Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Tofacitinib Players to Combat Covid-19 Impact
Table 15. Global Tofacitinib Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 16. Global Tofacitinib Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 17. Global Tofacitinib Sales by Regions 2015-2020 (K Pcs)
Table 18. Global Tofacitinib Sales Market Share by Regions (2015-2020)
Table 19. Global Tofacitinib Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Tofacitinib Sales by Manufacturers (2015-2020) (K Pcs)
Table 21. Global Tofacitinib Sales Share by Manufacturers (2015-2020)
Table 22. Global Tofacitinib Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Tofacitinib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tofacitinib as of 2019)
Table 24. Tofacitinib Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Tofacitinib Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Tofacitinib Price (2015-2020) (USD/Pcs)
Table 27. Tofacitinib Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Tofacitinib Product Type
Table 29. Date of International Manufacturers Enter into Tofacitinib Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 32. Global Tofacitinib Sales Share by Type (2015-2020)
Table 33. Global Tofacitinib Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Tofacitinib Revenue Share by Type (2015-2020)
Table 35. Tofacitinib Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 36. Global Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 37. Global Tofacitinib Sales Share by Application (2015-2020)
Table 38. North America Tofacitinib Sales by Country (2015-2020) (K Pcs)
Table 39. North America Tofacitinib Sales Market Share by Country (2015-2020)
Table 40. North America Tofacitinib Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Tofacitinib Revenue Market Share by Country (2015-2020)
Table 42. North America Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 43. North America Tofacitinib Sales Market Share by Type (2015-2020)
Table 44. North America Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 45. North America Tofacitinib Sales Market Share by Application (2015-2020)
Table 46. Europe Tofacitinib Sales by Country (2015-2020) (K Pcs)
Table 47. Europe Tofacitinib Sales Market Share by Country (2015-2020)
Table 48. Europe Tofacitinib Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Tofacitinib Revenue Market Share by Country (2015-2020)
Table 50. Europe Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 51. Europe Tofacitinib Sales Market Share by Type (2015-2020)
Table 52. Europe Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 53. Europe Tofacitinib Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Tofacitinib Sales by Region (2015-2020) (K Pcs)
Table 55. Asia Pacific Tofacitinib Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Tofacitinib Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Tofacitinib Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 59. Asia Pacific Tofacitinib Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 61. Asia Pacific Tofacitinib Sales Market Share by Application (2015-2020)
Table 62. Latin America Tofacitinib Sales by Country (2015-2020) (K Pcs)
Table 63. Latin America Tofacitinib Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Tofacitinib Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Tofacitinib Revenue Market Share by Country (2015-2020)
Table 66. Latin America Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 67. Latin America Tofacitinib Sales Market Share by Type (2015-2020)
Table 68. Latin America Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 69. Latin America Tofacitinib Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Tofacitinib Sales by Country (2015-2020) (K Pcs)
Table 71. Middle East and Africa Tofacitinib Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Tofacitinib Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Tofacitinib Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 75. Middle East and Africa Tofacitinib Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 77. Middle East and Africa Tofacitinib Sales Market Share by Application (2015-2020)
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Major Businesses
Table 80. Pfizer Tofacitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Pfizer Product
Table 82. Pfizer Recent Development
Table 83. Globe Pharmaceuticals Corporation Information
Table 84. Globe Pharmaceuticals Description and Major Businesses
Table 85. Globe Pharmaceuticals Tofacitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Globe Pharmaceuticals Product
Table 87. Globe Pharmaceuticals Recent Development
Table 88. Delta Pharma Limited Corporation Information
Table 89. Delta Pharma Limited Description and Major Businesses
Table 90. Delta Pharma Limited Tofacitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Delta Pharma Limited Product
Table 92. Delta Pharma Limited Recent Development
Table 93. Beacon Pharmaceuticals Corporation Information
Table 94. Beacon Pharmaceuticals Description and Major Businesses
Table 95. Beacon Pharmaceuticals Tofacitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Beacon Pharmaceuticals Product
Table 97. Beacon Pharmaceuticals Recent Development
Table 98. Drug International Corporation Information
Table 99. Drug International Description and Major Businesses
Table 100. Drug International Tofacitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Drug International Product
Table 102. Drug International Recent Development
Table 103. Global Tofacitinib Sales Forecast by Regions (2021-2026) (K Pcs)
Table 104. Global Tofacitinib Sales Market Share Forecast by Regions (2021-2026)
Table 105. Global Tofacitinib Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 106. Global Tofacitinib Revenue Market Share Forecast by Regions (2021-2026)
Table 107. North America: Tofacitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. North America: Tofacitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Europe: Tofacitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Europe: Tofacitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Asia Pacific: Tofacitinib Sales Forecast by Region (2021-2026) (K Pcs)
Table 112. Asia Pacific: Tofacitinib Revenue Forecast by Region (2021-2026) (US$ Million)
Table 113. Latin America: Tofacitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Latin America: Tofacitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Middle East and Africa: Tofacitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 116. Middle East and Africa: Tofacitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 118. Key Challenges
Table 119. Market Risks
Table 120. Main Points Interviewed from Key Tofacitinib Players
Table 121. Tofacitinib Customers List
Table 122. Tofacitinib Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 1. Tofacitinib Market Segments
Table 2. Ranking of Global Top Tofacitinib Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Tofacitinib Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 5mg*60 Tablets
Table 5. Major Manufacturers of 5mg*10 Tablets
Table 6. Major Manufacturers of 10mg*10 Tablets
Table 7. Major Manufacturers of 5mg*30 Tablets
Table 8. Major Manufacturers of 5mg*14 Tablets
Table 9. Major Manufacturers of 10mg*14 Tablets
Table 10. COVID-19 Impact Global Market: (Four Tofacitinib Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Tofacitinib Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Tofacitinib Players to Combat Covid-19 Impact
Table 15. Global Tofacitinib Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 16. Global Tofacitinib Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 17. Global Tofacitinib Sales by Regions 2015-2020 (K Pcs)
Table 18. Global Tofacitinib Sales Market Share by Regions (2015-2020)
Table 19. Global Tofacitinib Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Tofacitinib Sales by Manufacturers (2015-2020) (K Pcs)
Table 21. Global Tofacitinib Sales Share by Manufacturers (2015-2020)
Table 22. Global Tofacitinib Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Tofacitinib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tofacitinib as of 2019)
Table 24. Tofacitinib Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Tofacitinib Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Tofacitinib Price (2015-2020) (USD/Pcs)
Table 27. Tofacitinib Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Tofacitinib Product Type
Table 29. Date of International Manufacturers Enter into Tofacitinib Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 32. Global Tofacitinib Sales Share by Type (2015-2020)
Table 33. Global Tofacitinib Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Tofacitinib Revenue Share by Type (2015-2020)
Table 35. Tofacitinib Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 36. Global Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 37. Global Tofacitinib Sales Share by Application (2015-2020)
Table 38. North America Tofacitinib Sales by Country (2015-2020) (K Pcs)
Table 39. North America Tofacitinib Sales Market Share by Country (2015-2020)
Table 40. North America Tofacitinib Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Tofacitinib Revenue Market Share by Country (2015-2020)
Table 42. North America Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 43. North America Tofacitinib Sales Market Share by Type (2015-2020)
Table 44. North America Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 45. North America Tofacitinib Sales Market Share by Application (2015-2020)
Table 46. Europe Tofacitinib Sales by Country (2015-2020) (K Pcs)
Table 47. Europe Tofacitinib Sales Market Share by Country (2015-2020)
Table 48. Europe Tofacitinib Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Tofacitinib Revenue Market Share by Country (2015-2020)
Table 50. Europe Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 51. Europe Tofacitinib Sales Market Share by Type (2015-2020)
Table 52. Europe Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 53. Europe Tofacitinib Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Tofacitinib Sales by Region (2015-2020) (K Pcs)
Table 55. Asia Pacific Tofacitinib Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Tofacitinib Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Tofacitinib Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 59. Asia Pacific Tofacitinib Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 61. Asia Pacific Tofacitinib Sales Market Share by Application (2015-2020)
Table 62. Latin America Tofacitinib Sales by Country (2015-2020) (K Pcs)
Table 63. Latin America Tofacitinib Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Tofacitinib Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Tofacitinib Revenue Market Share by Country (2015-2020)
Table 66. Latin America Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 67. Latin America Tofacitinib Sales Market Share by Type (2015-2020)
Table 68. Latin America Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 69. Latin America Tofacitinib Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Tofacitinib Sales by Country (2015-2020) (K Pcs)
Table 71. Middle East and Africa Tofacitinib Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Tofacitinib Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Tofacitinib Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Tofacitinib Sales by Type (2015-2020) (K Pcs)
Table 75. Middle East and Africa Tofacitinib Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Tofacitinib Sales by Application (2015-2020) (K Pcs)
Table 77. Middle East and Africa Tofacitinib Sales Market Share by Application (2015-2020)
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Major Businesses
Table 80. Pfizer Tofacitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Pfizer Product
Table 82. Pfizer Recent Development
Table 83. Globe Pharmaceuticals Corporation Information
Table 84. Globe Pharmaceuticals Description and Major Businesses
Table 85. Globe Pharmaceuticals Tofacitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Globe Pharmaceuticals Product
Table 87. Globe Pharmaceuticals Recent Development
Table 88. Delta Pharma Limited Corporation Information
Table 89. Delta Pharma Limited Description and Major Businesses
Table 90. Delta Pharma Limited Tofacitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Delta Pharma Limited Product
Table 92. Delta Pharma Limited Recent Development
Table 93. Beacon Pharmaceuticals Corporation Information
Table 94. Beacon Pharmaceuticals Description and Major Businesses
Table 95. Beacon Pharmaceuticals Tofacitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Beacon Pharmaceuticals Product
Table 97. Beacon Pharmaceuticals Recent Development
Table 98. Drug International Corporation Information
Table 99. Drug International Description and Major Businesses
Table 100. Drug International Tofacitinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Drug International Product
Table 102. Drug International Recent Development
Table 103. Global Tofacitinib Sales Forecast by Regions (2021-2026) (K Pcs)
Table 104. Global Tofacitinib Sales Market Share Forecast by Regions (2021-2026)
Table 105. Global Tofacitinib Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 106. Global Tofacitinib Revenue Market Share Forecast by Regions (2021-2026)
Table 107. North America: Tofacitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. North America: Tofacitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Europe: Tofacitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Europe: Tofacitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Asia Pacific: Tofacitinib Sales Forecast by Region (2021-2026) (K Pcs)
Table 112. Asia Pacific: Tofacitinib Revenue Forecast by Region (2021-2026) (US$ Million)
Table 113. Latin America: Tofacitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Latin America: Tofacitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Middle East and Africa: Tofacitinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 116. Middle East and Africa: Tofacitinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 118. Key Challenges
Table 119. Market Risks
Table 120. Main Points Interviewed from Key Tofacitinib Players
Table 121. Tofacitinib Customers List
Table 122. Tofacitinib Distributors List
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Tofacitinib Product Picture
Figure 2. Global Tofacitinib Sales Market Share by Type in 2020 & 2026
Figure 3. 5mg*60 Tablets Product Picture
Figure 4. 5mg*10 Tablets Product Picture
Figure 5. 10mg*10 Tablets Product Picture
Figure 6. 5mg*30 Tablets Product Picture
Figure 7. 5mg*14 Tablets Product Picture
Figure 8. 10mg*14 Tablets Product Picture
Figure 9. Global Tofacitinib Sales Market Share by Application in 2020 & 2026
Figure 10. Rheumatoid Arthritis
Figure 11. Ulcerative Colitis
Figure 12. Psoriasis
Figure 13. Other
Figure 14. Tofacitinib Report Years Considered
Figure 15. Global Tofacitinib Market Size 2015-2026 (US$ Million)
Figure 16. Global Tofacitinib Sales 2015-2026 (K Pcs)
Figure 17. Global Tofacitinib Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Tofacitinib Sales Market Share by Region (2015-2020)
Figure 19. Global Tofacitinib Sales Market Share by Region in 2019
Figure 20. Global Tofacitinib Revenue Market Share by Region (2015-2020)
Figure 21. Global Tofacitinib Revenue Market Share by Region in 2019
Figure 22. Global Tofacitinib Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Tofacitinib Revenue in 2019
Figure 24. Tofacitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Tofacitinib Sales Market Share by Type (2015-2020)
Figure 26. Global Tofacitinib Sales Market Share by Type in 2019
Figure 27. Global Tofacitinib Revenue Market Share by Type (2015-2020)
Figure 28. Global Tofacitinib Revenue Market Share by Type in 2019
Figure 29. Global Tofacitinib Market Share by Price Range (2015-2020)
Figure 30. Global Tofacitinib Sales Market Share by Application (2015-2020)
Figure 31. Global Tofacitinib Sales Market Share by Application in 2019
Figure 32. Global Tofacitinib Revenue Market Share by Application (2015-2020)
Figure 33. Global Tofacitinib Revenue Market Share by Application in 2019
Figure 34. North America Tofacitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Tofacitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Tofacitinib Sales Market Share by Country in 2019
Figure 37. North America Tofacitinib Revenue Market Share by Country in 2019
Figure 38. U.S. Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Tofacitinib Market Share by Type in 2019
Figure 43. North America Tofacitinib Market Share by Application in 2019
Figure 44. Europe Tofacitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Tofacitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Tofacitinib Sales Market Share by Country in 2019
Figure 47. Europe Tofacitinib Revenue Market Share by Country in 2019
Figure 48. Germany Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Tofacitinib Market Share by Type in 2019
Figure 59. Europe Tofacitinib Market Share by Application in 2019
Figure 60. Asia Pacific Tofacitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Tofacitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Tofacitinib Sales Market Share by Region in 2019
Figure 63. Asia Pacific Tofacitinib Revenue Market Share by Region in 2019
Figure 64. China Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Tofacitinib Market Share by Type in 2019
Figure 87. Asia Pacific Tofacitinib Market Share by Application in 2019
Figure 88. Latin America Tofacitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Tofacitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Tofacitinib Sales Market Share by Country in 2019
Figure 91. Latin America Tofacitinib Revenue Market Share by Country in 2019
Figure 92. Mexico Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Tofacitinib Market Share by Type in 2019
Figure 99. Latin America Tofacitinib Market Share by Application in 2019
Figure 100. Middle East and Africa Tofacitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Tofacitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Tofacitinib Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Tofacitinib Revenue Market Share by Country in 2019
Figure 104. Turkey Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Tofacitinib Market Share by Type in 2019
Figure 111. Middle East and Africa Tofacitinib Market Share by Application in 2019
Figure 112. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Globe Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Delta Pharma Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Beacon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Drug International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Tofacitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. North America Tofacitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Tofacitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Europe Tofacitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Tofacitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Asia Pacific Tofacitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Tofacitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 124. Latin America Tofacitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Tofacitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 126. Middle East and Africa Tofacitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
Figure 1. Tofacitinib Product Picture
Figure 2. Global Tofacitinib Sales Market Share by Type in 2020 & 2026
Figure 3. 5mg*60 Tablets Product Picture
Figure 4. 5mg*10 Tablets Product Picture
Figure 5. 10mg*10 Tablets Product Picture
Figure 6. 5mg*30 Tablets Product Picture
Figure 7. 5mg*14 Tablets Product Picture
Figure 8. 10mg*14 Tablets Product Picture
Figure 9. Global Tofacitinib Sales Market Share by Application in 2020 & 2026
Figure 10. Rheumatoid Arthritis
Figure 11. Ulcerative Colitis
Figure 12. Psoriasis
Figure 13. Other
Figure 14. Tofacitinib Report Years Considered
Figure 15. Global Tofacitinib Market Size 2015-2026 (US$ Million)
Figure 16. Global Tofacitinib Sales 2015-2026 (K Pcs)
Figure 17. Global Tofacitinib Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Tofacitinib Sales Market Share by Region (2015-2020)
Figure 19. Global Tofacitinib Sales Market Share by Region in 2019
Figure 20. Global Tofacitinib Revenue Market Share by Region (2015-2020)
Figure 21. Global Tofacitinib Revenue Market Share by Region in 2019
Figure 22. Global Tofacitinib Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Tofacitinib Revenue in 2019
Figure 24. Tofacitinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Tofacitinib Sales Market Share by Type (2015-2020)
Figure 26. Global Tofacitinib Sales Market Share by Type in 2019
Figure 27. Global Tofacitinib Revenue Market Share by Type (2015-2020)
Figure 28. Global Tofacitinib Revenue Market Share by Type in 2019
Figure 29. Global Tofacitinib Market Share by Price Range (2015-2020)
Figure 30. Global Tofacitinib Sales Market Share by Application (2015-2020)
Figure 31. Global Tofacitinib Sales Market Share by Application in 2019
Figure 32. Global Tofacitinib Revenue Market Share by Application (2015-2020)
Figure 33. Global Tofacitinib Revenue Market Share by Application in 2019
Figure 34. North America Tofacitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Tofacitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Tofacitinib Sales Market Share by Country in 2019
Figure 37. North America Tofacitinib Revenue Market Share by Country in 2019
Figure 38. U.S. Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Tofacitinib Market Share by Type in 2019
Figure 43. North America Tofacitinib Market Share by Application in 2019
Figure 44. Europe Tofacitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Tofacitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Tofacitinib Sales Market Share by Country in 2019
Figure 47. Europe Tofacitinib Revenue Market Share by Country in 2019
Figure 48. Germany Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Tofacitinib Market Share by Type in 2019
Figure 59. Europe Tofacitinib Market Share by Application in 2019
Figure 60. Asia Pacific Tofacitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Tofacitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Tofacitinib Sales Market Share by Region in 2019
Figure 63. Asia Pacific Tofacitinib Revenue Market Share by Region in 2019
Figure 64. China Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Tofacitinib Market Share by Type in 2019
Figure 87. Asia Pacific Tofacitinib Market Share by Application in 2019
Figure 88. Latin America Tofacitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Tofacitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Tofacitinib Sales Market Share by Country in 2019
Figure 91. Latin America Tofacitinib Revenue Market Share by Country in 2019
Figure 92. Mexico Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Tofacitinib Market Share by Type in 2019
Figure 99. Latin America Tofacitinib Market Share by Application in 2019
Figure 100. Middle East and Africa Tofacitinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Tofacitinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Tofacitinib Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Tofacitinib Revenue Market Share by Country in 2019
Figure 104. Turkey Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Tofacitinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Tofacitinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Tofacitinib Market Share by Type in 2019
Figure 111. Middle East and Africa Tofacitinib Market Share by Application in 2019
Figure 112. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Globe Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Delta Pharma Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Beacon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Drug International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Tofacitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. North America Tofacitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Tofacitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Europe Tofacitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Tofacitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Asia Pacific Tofacitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Tofacitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 124. Latin America Tofacitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Tofacitinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 126. Middle East and Africa Tofacitinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
